Crosstalk Between ROS and Autophagy in Tumorigenesis: Understanding the Multifaceted Paradox
Authors:
Open Access
- 10 March 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 12, 852424
Abstract
Cancer formation is a highly regulated and complex process, largely dependent on its microenvironment. This complexity highlights the need for developing novel target-based therapies depending on cancer phenotype and genotype. Autophagy, a catabolic process, removes damaged and defective cellular materials through lysosomes. It is activated in response to stress conditions such as nutrient deprivation, hypoxia, and oxidative stress. Oxidative stress is induced by excess reactive oxygen species (ROS) that are multifaceted molecules that drive several pathophysiological conditions, including cancer. Moreover, autophagy also plays a dual role, initially inhibiting tumor formation but promoting tumor progression during advanced stages. Mounting evidence has suggested an intricate crosstalk between autophagy and ROS where they can either suppress cancer formation or promote disease etiology. This review highlights the regulatory roles of autophagy and ROS from tumor induction to metastasis. We also discuss the therapeutic strategies that have been devised so far to combat cancer. Based on the review, we finally present some gap areas that could be targeted and may provide a basis for cancer suppression.Keywords
This publication has 293 references indexed in Scilit:
- Antiproliferative mechanisms of action of the flavin dehydrogenase inhibitors diphenylene iodonium and di-2-thienyliodonium based on molecular profiling of the NCI-60 human tumor cell panelBiochemical Pharmacology, 2012
- Terfenadine induces apoptosis and autophagy in melanoma cells through ROS-dependent and -independent mechanismsApoptosis, 2011
- The Multifaceted Roles of Autophagy in Tumors—Implications for Breast CancerJournal of Mammary Gland Biology and Neoplasia, 2011
- Stressin' Sestrins take an aging fightEMBO Molecular Medicine, 2010
- Hypoxia-induced autophagy: cell death or cell survival?Current Opinion in Cell Biology, 2010
- Cellular Responses to Cancer Chemopreventive Agent D,L-Sulforaphane in Human Prostate Cancer Cells Are Initiated by Mitochondrial Reactive Oxygen SpeciesPharmaceutical Research, 2009
- Autophagy in the Pathogenesis of DiseaseCell, 2008
- Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesisCancer Cell, 2006
- ROS stress in cancer cells and therapeutic implicationsDrug Resistance Updates, 2004
- The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapiesThe Journal of Pathology, 2002